185015515	185015515	CD	B-NP	O
|	|	NN	I-NP	O
GSH	GSH	NN	I-NP	O
|	|	NN	I-NP	O
57434547	57434547	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6326250	6326250	CD	B-NP	O
|	|	CC	I-NP	O
11/9/2007	11/9/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Non-cardiac	Non-cardiac	JJ	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/27/2007	5/27/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/27/2007	5/27/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
PACLEB	PACLEB	NNP	B-NP	O
,	,	,	O	O
DENNY	DENNY	NNP	B-NP	O
H	H	NNP	I-NP	O
765-89-37-7	765-89-37-7	NNP	I-NP	O
Cico	Cico	NNP	I-NP	O
Ona	Ona	NNP	I-NP	O
Rage	Rage	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
5/3/07	5/3/07	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GREFRATH	GREFRATH	NNP	B-NP	O
,	,	,	O	O
STUART	STUART	NNP	B-NP	O
ABDUL	ABDUL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

ACETAMINOPHEN	ACETAMINOPHEN	NN	B-NP	O
650	650	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

ATENOLOL	ATENOLOL	NN	B-NP	O
25	25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

CALCIUM	CALCIUM	NN	B-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
ELEMENTAL	ELEMENTAL	NN	I-NP	O
CA	CA	NN	I-NP	O
+	+	SYM	B-VP	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	O	O
1500	1500	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

DOCUSATE	DOCUSATE	JJ	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

FERROUS	FERROUS	DT	B-NP	O
SULFATE	SULFATE	JJ	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	B-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

FLUTICASONE	FLUTICASONE	NNP	B-NP	O
NASAL	NASAL	NNP	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
1-2	1-2	CD	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
NA	NA	NN	I-NP	B-protein
QD	QD	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

FOLIC	FOLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

KCL	KCL	NN	B-NP	O
SLOW	SLOW	NN	I-NP	O
RELEASE	RELEASE	NN	I-NP	O
TAB	TAB	NN	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

MULTIVITAMINS	MULTIVITAMINS	NN	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
Q5MIN	Q5MIN	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

OMEPRAZOLE	OMEPRAZOLE	IN	B-PP	O
20	20	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

OXYCODONE	OXYCODONE	RB	B-NP	O
10-15	10-15	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q3H	Q3H	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

PSYLLIUM	PSYLLIUM	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
METAMUCIL	METAMUCIL	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
SUGAR	SUGAR	NN	I-NP	I-protein
FREE	FREE	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
PACKET	PACKET	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NNP	B-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

SENNOSIDES	SENNOSIDES	NNS	B-NP	O
2	2	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

TRAMADOL	TRAMADOL	NN	B-NP	O
50-100	50-100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

TRIAMTERENE	TRIAMTERENE	NN	B-NP	B-protein
75	75	CD	I-NP	I-protein
MG/HYDROCHLOROTHIAZIDE	MG/HYDROCHLOROTHIAZIDE	NN	I-NP	I-protein
50	50	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
1	1	CD	B-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
18	18	CD	I-NP	I-protein
.	.	.	O	O

VALSARTAN	VALSARTAN	IN	B-PP	O
40	40	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
19	19	CD	I-NP	O
.	.	.	O	O

DOCUSATE	DOCUSATE	JJ	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
ECASA	ECASA	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/18	7/18	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/3/07	5/3/07	CD	B-NP	O
by	by	IN	B-PP	O
MONEY	MONEY	NNP	B-NP	O
,	,	,	O	O
RON	RON	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
840863602	840863602	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
/	/	SYM	B-VP	O
VIT	VIT	NN	B-NP	B-protein
D	D	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
,	,	,	I-NP	O
500	500	CD	I-NP	O
MG/200	MG/200	NN	I-NP	O
IU	IU	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
600	600	CD	I-NP	B-DNA
MG	MG	NN	I-NP	I-DNA
ELEM	ELEM	NN	I-NP	I-DNA
CA	CA	NN	I-NP	I-DNA
-RRB-	-RRB-	HYPH	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
TAB	TAB	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
DAILY	DAILY	NN	I-NP	I-DNA
COLACE	COLACE	NN	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
DOCUSATE	DOCUSATE	NNP	I-NP	I-DNA
SODIUM	SODIUM	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
100	100	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
TID	TID	NNP	I-NP	I-DNA
FERROUS	FERROUS	NNP	I-NP	I-DNA
SULFATE	SULFATE	NNP	I-NP	I-DNA
325	325	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
TID	TID	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
milk	milk	NN	I-NP	I-DNA
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	B-protein
FLUTICASONE	FLUTICASONE	NNP	I-NP	I-protein
NASAL	NASAL	NNP	I-NP	I-protein
SPRAY	SPRAY	NNP	I-NP	I-protein
2	2	CD	I-NP	I-protein
SPRAY	SPRAY	NNP	I-NP	I-protein
INH	INH	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
FOLATE	FOLATE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FOLIC	FOLIC	NNP	I-NP	I-protein
ACID	ACID	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
K-DUR	K-DUR	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
KCL	KCL	NNP	I-NP	I-protein
SLOW	SLOW	NNP	I-NP	I-protein
RELEASE	RELEASE	NNP	I-NP	I-protein
TAB	TAB	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
MPCHCOC	MPCHCOC	NN	B-NP	O
Potassium	Potassium	NN	I-NP	O
Chloride	Chloride	NN	I-NP	O
Policy	Policy	NN	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/3/07	5/3/07	CD	B-NP	O
by	by	IN	B-PP	O
WORLIE	WORLIE	NNP	B-NP	O
,	,	,	O	O
ROMEO	ROMEO	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
VALSARTAN	VALSARTAN	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
755926226	755926226	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/3/07	5/3/07	CD	B-NP	O
by	by	IN	B-PP	O
ROUZZO	ROUZZO	NNP	B-NP	O
,	,	,	O	O
LEWIS	LEWIS	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TRIAMTERENE	TRIAMTERENE	NN	B-NP	B-protein
37.5	37.5	CD	I-NP	I-protein
MG/HYDROCHLOROTHIAZIDE	MG/HYDROCHLOROTHIAZIDE	NN	I-NP	I-protein
25	25	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
CAP	CAP	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
588622159	588622159	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
TRIAMTERENE	TRIAMTERENE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	O
1/150	1/150	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
q5min	q5min	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
PRN	PRN	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
OMEPRAZOLE	OMEPRAZOLE	NN	I-NP	O
20	20	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
OXYCODONE	OXYCODONE	NNP	I-NP	O
10-15	10-15	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/18	7/18	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
sedation	sedation	NN	B-NP	O
,	,	,	O	O
RR	RR	NN	B-NP	B-protein
<	<	SYM	B-NP	I-protein
10	10	CD	B-NP	I-protein
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/3/07	5/3/07	CD	B-NP	O
by	by	IN	B-PP	O
LIGON	LIGON	NNP	B-NP	O
,	,	,	O	O
LAVERN	LAVERN	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ULTRAM	ULTRAM	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
224697408	224697408	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
OXYCODONE	OXYCODONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
TRAMADOL	TRAMADOL	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
medication	medication	NN	I-NP	O
METAMUCIL	METAMUCIL	NN	I-NP	O
SUGAR	SUGAR	NN	I-NP	O
FREE	FREE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PSYLLIUM	PSYLLIUM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METAMUCIL	METAMUCIL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
SU	SU	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	NN	B-NP	B-protein
1-2	1-2	CD	I-NP	I-protein
PACKET	PACKET	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Constipation	Constipation	NNP	I-NP	I-protein
SENNA	SENNA	NNP	I-NP	I-protein
TABLETS	TABLETS	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
SENNOSIDES	SENNOSIDES	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
MULTIVI	MULTIVI	NN	I-NP	I-protein
...	...	:	O	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/3/07	5/3/07	CD	B-NP	O
by	by	IN	B-PP	O
TIPPS	TIPPS	NNP	B-NP	O
,	,	,	O	O
JONATHON	JONATHON	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
ULTRAM	ULTRAM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TRAMADOL	TRAMADOL	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
50	50	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/18	7/18	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/3/07	5/3/07	CD	B-NP	O
by	by	IN	B-PP	O
STAHNKE	STAHNKE	NN	B-NP	O
,	,	,	O	O
HOWARD	HOWARD	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
TRAMADOL	TRAMADOL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
OXYCODONE	OXYCODONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
TRAMADOL	TRAMADOL	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
medication	medication	NN	I-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
TRIAMTERENE	TRIAMTERENE	NN	I-NP	O
37.5	37.5	CD	B-NP	O
MG/HYDROCHLOROTHIAZIDE	MG/HYDROCHLOROTHIAZIDE	NN	I-NP	O
25	25	CD	B-NP	O
MG	MG	NN	I-NP	O
CAP	CAP	NN	I-NP	O
1	1	CD	I-NP	O
CAPSULE	CAPSULE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/3/07	5/3/07	CD	B-NP	O
by	by	IN	B-PP	O
PHILEN	PHILEN	NNP	B-NP	O
,	,	,	O	O
EMIL	EMIL	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TRIAMTERENE	TRIAMTERENE	NN	B-NP	B-protein
37.5	37.5	CD	I-NP	I-protein
MG/HYDROCHLOROTHIAZIDE	MG/HYDROCHLOROTHIAZIDE	NN	I-NP	I-protein
25	25	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
CAP	CAP	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	O
588622159	588622159	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
ALOPECIA	ALOPECIA	NNP	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/3/07	5/3/07	CD	B-NP	O
by	by	IN	B-PP	O
MCLEESE	MCLEESE	NNP	B-NP	O
,	,	,	O	O
GARRY	GARRY	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
TRIAMTERENE	TRIAMTERENE	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
TRIAMTERENE	TRIAMTERENE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
VALSARTAN	VALSARTAN	NNP	B-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/3/07	5/3/07	CD	B-NP	O
by	by	IN	B-PP	O
BORDAS	BORDAS	NNP	B-NP	O
,	,	,	O	O
TRACY	TRACY	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/3/07	5/3/07	CD	B-NP	O
by	by	IN	B-PP	O
RAPER	RAPER	NN	B-NP	B-protein
,	,	,	O	O
SIMON	SIMON	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ULTRAM	ULTRAM	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
224697408	224697408	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
TRAMADOL	TRAMADOL	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
medication	medication	NN	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/3/07	5/3/07	CD	B-NP	O
by	by	IN	B-PP	O
SENGVILAY	SENGVILAY	NNP	B-NP	O
,	,	,	O	O
KORY	KORY	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Logwood	Logwood	NNP	I-NP	O
5/9	5/9	CD	I-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Rarden	Rarden	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
please	please	VB	B-VP	O
call	call	NN	B-NP	O
to	to	TO	B-VP	O
set	set	VB	I-VP	O
up	up	RP	B-PRT	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Non-cardiac	Non-cardiac	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
htn	htn	NN	I-NP	O
obesity	obesity	NN	I-NP	O
h/o	h/o	NN	I-NP	O
sarcoid	sarcoid	NN	I-NP	O
arthritis	arthritis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
polyarticular	polyarticular	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
diverticulosis	diverticulosis	NN	I-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
depression	depression	NN	I-NP	O
Recurrent	Recurrent	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
clean	clean	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
66yoF	66yoF	NN	B-NP	O
w/obesity	w/obesity	NN	I-NP	O
,	,	,	O	O
sarcoid	sarcoid	JJ	B-NP	O
,	,	,	I-NP	O
chronic	chronic	JJ	I-NP	O
non-cardiac	non-cardiac	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
clean	clean	JJ	B-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
2005	2005	CD	B-NP	O
,	,	,	O	O
PE	PE	NNP	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
THR	THR	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
p/w	p/w	VBP	B-VP	O
SSCP	SSCP	NN	B-NP	O
x1	x1	NN	I-NP	O
hr	hr	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
w/SOB	w/SOB	NN	I-NP	O
.	.	.	O	O

Dev	Dev	NN	B-NP	O
'd	'd	MD	B-VP	O
SSCP	SSCP	NN	B-NP	O
while	while	IN	B-SBAR	O
seated	seat	VBN	B-VP	O
on	on	IN	B-PP	O
DOA	DOA	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
radiation	radiation	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
+	+	JJ	B-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
and	and	CC	I-NP	O
n/v	n/v	NN	I-NP	O
.	.	.	O	O

Took	Took	NNP	B-NP	O
ASA	ASA	NNP	I-NP	O
and	and	CC	O	O
came	come	VBD	B-VP	O
to	to	TO	B-VP	O
ED	ED	VB	I-VP	O
where	where	WRB	B-ADVP	O
pain	pain	NN	B-NP	O
and	and	CC	I-NP	O
SOB	SOB	NN	I-NP	B-protein
spontaneously	spontaneously	RB	B-ADVP	O
resolved	resolve	VBD	B-VP	O
w/o	w/o	NN	B-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
w/no	w/no	VBD	B-VP	O
new	new	JJ	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

First	First	NNP	B-NP	O
Tn	Tn	NNP	I-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

Admitted	Admit	VBN	B-VP	O
for	for	IN	B-PP	O
roMI	roMI	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
sarcoidosis	sarcoidosis	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
recurrent	recurrent	JJ	I-NP	O
SSCP	SSCP	NN	I-NP	O
-	-	HYPH	B-NP	O
clean	clean	JJ	I-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
2005	2005	CD	B-NP	O
,	,	,	O	O
PE	PE	NNP	B-NP	O
's	's	POS	B-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
THR	THR	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
OA	OA	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
osteoporosis	osteoporosis	NN	B-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
DAILY	DAILY	NN	I-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
afeb	afeb	NN	B-NP	O
,	,	,	O	O
140/90	140/90	CD	B-NP	O
,	,	,	I-NP	O
60	60	CD	I-NP	O
,	,	,	I-NP	O
99	99	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

NAD	NAD	NN	B-NP	O
,	,	,	I-NP	O
pain	pain	NN	I-NP	O
free	free	JJ	I-NP	O
.	.	.	O	O

RRR	RRR	NN	B-NP	B-protein
no	no	DT	B-NP	O
mrg	mrg	NN	I-NP	O
,	,	,	O	O
CTA	CTA	NNP	B-NP	O
B.	B.	NNP	I-NP	O
mild	mild	JJ	I-NP	O
chest	chest	NN	I-NP	O
wall	wall	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

SNTND	SNTND	NN	B-NP	O
+	+	SYM	I-NP	O
BS	BS	NN	I-NP	O
.	.	.	O	O

no	no	DT	B-NP	O
LEE	LEE	NN	I-NP	B-protein
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
STUDIES	STUDIES	NNS	B-NP	O
:	:	:	O	O
CXR	CXR	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
hilar	hilar	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
+	+	SYM	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
11/27/07	11/27/07	CD	B-NP	O
-	-	HYPH	I-NP	O
NSR	NSR	NN	I-NP	B-protein
,	,	,	O	O
TWI	TWI	NN	B-NP	O
in	in	IN	B-PP	O
III	III	CD	B-NP	O
,	,	,	O	O
F	F	NNP	B-NP	O
,	,	,	O	O
II	II	CD	B-NP	O
-LRB-	-LRB-	HYPH	O	O
all	all	DT	B-NP	O
old	old	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	O	O
***************	***************	SYM	B-NP	B-cell_type
HOSPITAL	HOSPITAL	NN	I-NP	I-cell_type
COURSE	COURSE	NN	I-NP	I-cell_type
******************	******************	SYM	O	I-cell_type
*	*	SYM	O	O
CVS	CVS	NN	B-NP	O
:	:	:	O	O
p/w	p/w	NN	B-NP	O
SSCP	SSCP	NN	I-NP	O
that	that	IN	B-NP	O
spontaneously	spontaneously	RB	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
biomarkers	biomarker	NNS	I-NP	O
neg	neg	NN	I-NP	O
x	x	SYM	O	O
2	2	CD	B-NP	O
12	12	CD	I-NP	O
hours	hour	NNS	I-NP	O
apart	apart	RB	B-ADVP	O
.	.	.	O	O

Has	Has	IN	B-PP	O
a	a	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
atypical	atypical	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
with	with	IN	B-PP	O
frequent	frequent	JJ	B-NP	O
rule	rule	NN	I-NP	O
outs	out	NNS	I-NP	O
and	and	CC	O	O
clean	clean	JJ	B-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
2005	2005	CD	B-NP	O
.	.	.	O	O

Very	Very	RB	B-NP	O
low	low	JJ	I-NP	O
likelihood	likelihood	NN	I-NP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
pain	pain	NN	I-NP	O
given	give	VBN	B-VP	O
prior	prior	JJ	B-NP	O
hx	hx	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ekg	ekg	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	I-NP	O
neg	neg	NN	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

May	May	NNP	B-NP	O
consider	consider	VB	B-VP	O
Ad-MIBI	Ad-MIBI	NNP	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
interpret	interpret	VB	I-VP	O
given	give	VBN	I-VP	O
large	large	JJ	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
anti-HTN	anti-HTN	NN	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
BB	BB	NNP	B-NP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
sarcoid	sarcoid	NN	B-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
not	not	RB	O	O
on	on	IN	B-PP	O
meds	med	NNS	B-NP	O
currently	currently	RB	B-ADVP	O
.	.	.	O	O

hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
therapeutic	therapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
currently	currently	RB	B-ADVP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
inhalers	inhaler	NNS	I-NP	O
*	*	SYM	B-NP	O
ORTHO	ORTHO	NN	I-NP	O
:	:	:	O	O
recent	recent	JJ	B-NP	O
L	L	NN	I-NP	O
THR	THR	NN	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
ppx	ppx	NN	I-NP	O
.	.	.	O	O

Has	Has	JJ	B-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Pennick	Pennick	NNP	I-NP	O
on	on	IN	B-PP	O
5/9	5/9	CD	B-NP	O
*	*	SYM	I-NP	O
ENDO	ENDO	NN	I-NP	O
:	:	:	O	O
questionable	questionable	JJ	B-NP	O
h/o	h/o	NN	I-NP	O
DM	DM	NN	I-NP	O
,	,	,	O	O
*	*	SYM	B-NP	O
PPX	PPX	NN	I-NP	B-protein
:	:	:	O	O
Coumadin	Coumadin	NN	B-NP	O
*	*	SYM	O	O
CODE	CODE	NN	B-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
were	be	VBD	B-VP	O
concerned	concern	VBN	B-ADJP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
chest	chest	VBP	B-VP	O
pain	pain	NN	B-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
from	from	IN	B-PP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
.	.	.	O	O

Fortunately	Fortunately	RB	B-NP	O
all	all	DT	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
muscle	muscle	NN	I-NP	O
protien	protien	NN	I-NP	O
test	test	NN	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
from	from	IN	B-PP	O
some	some	DT	B-NP	O
other	other	JJ	I-NP	O
source	source	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
and	and	CC	I-VP	O
make	make	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Wiebold	Wiebold	NNP	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
review	review	VB	I-VP	O
you	you	PRP	B-NP	O
medications	medication	NNS	B-NP	O
and	and	CC	O	O
discuss	discuss	VBP	B-VP	O
recent	recent	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
admissions	admission	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
recurrent	recurrent	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
concerning	concern	VBG	I-NP	O
sx	sx	NN	I-NP	O
please	please	NN	I-NP	O
contact	contact	VBP	B-VP	O
a	a	DT	B-NP	O
physician	physician	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
Consider	Consider	NN	I-NP	O
outpatient	outpatient	NN	I-NP	O
adenosine	adenosine	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
*	*	SYM	B-NP	O
Monitor	Monitor	NN	I-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
*	*	SYM	O	O
Continue	Continue	NN	B-NP	O
monitoring	monitor	VBG	B-VP	O
sarcoid	sarcoid	NN	B-NP	O
*	*	SYM	I-NP	O
Patient	Patient	NN	I-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
ortho	ortho	JJ	B-NP	O
regarding	regard	VBG	I-NP	O
recent	recent	JJ	I-NP	O
hip	hip	NN	I-NP	O
surgery	surgery	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
DAMES	DAMES	NNP	B-NP	O
,	,	,	O	O
STEVIE	STEVIE	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PL728	PL728	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/3/07	5/3/07	CD	I-NP	O
@	@	NN	I-NP	O
06	06	CD	I-NP	O
:	:	:	O	O
34	34	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

